Company Profile

Avsana Labs Inc
Profile last edited on: 3/2/2023      CAGE: 8SFX1      UEI: VKU9NKLFD1K8

Business Identifier: Developing new technologies for viral diagnostic testing, such as the COVID-19 virus.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1104 Morningstar Trl
Richardson, TX 75081
   (972) 883-4440
Location: Single
Congr. District: 32
County: Dallas

Public Profile

Avsana Labs is a biotechnology startup and spin-out company from the University of Texas at Dallas (UTD) that seeks to improve viral diagnostic testing using a cutting edge digital nanobubble methodology. Company aims to follow an accelerated path in bringing the technology to market, in collaboration with UTD and the University of Texas Southwestern Medical School (UTSW). Avsana intends to enable a significant societal benefit by helping to mitigate the spread of contagious viral infections, while ultimately helping to reduce the loss of life caused by both current and future pandemics. The intention is to develop a significantly improved test, in terms of speed, accuracy, and cost-effectiveness, for both existing and future viruses.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $596,416
Project Title: Rapid Viral Diagnostic Test by Digital Plasmonic Nanobubbles

Key People / Management

  Zhenpeng Qin -- Co-Founder and President

  Jeffrey L Kahn -- Chief Medical Officer And Chair Scientific Advisory Board

  Dennis I Robbins -- Co-Founder and Chairman, Board of Directors

  Nadine Van Zyl -- Co-Founder and VP Operations

Company News

There are no news available.